Active Ingredient History

NOW
  • Now
Eptinezumab, sold under the brand name Vyepti, is a medication used for the preventive treatment of migraine in adults. It is a monoclonal antibody that targets calcitonin gene-related peptides (CGRP) alpha and beta. It is administered by intravenous infusion.   Wikipedia

More Chemistry

Drug Pricing (per unit)

United States

$1119.0800 - $1479.9800
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

eptinezumab

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue